The application of in vitro data in the derivation of the acceptable daily intake of food additives

Food and Chemical Toxicology

Volumn 37, Issue 12, 1999, Pages 1175-1197

  Walton, K ^a   Walker, R ^b   Van De Sandt, J J M ^c   Castell, J V ^d   Knapp, A G A A ^e   Kozianowski, G ^f   Roberfroid, M ^g   Schilter, B ^h  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF SURREY   (United Kingdom)

^c TNO   (Netherlands)

^d HOSPITAL UNIVERSITARIO LA FE   (Spain)

^e NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^f Sudzucker AG Mannheim/Ochsenfurt   (Germany)

^g UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^h NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

Acceptable daily intake; Food additives; In vitro; Metabolism; Toxicodynamics and uncertainty factor; Toxicokinetics

Indexed keywords

2 HYDROXYBIPHENYL; ALUMINUM; ASPARTAME; BIPHENYL; BRILLIANT BLUE; BUTYLCRESOL; CURCUMIN; CYCLAMATE SODIUM; CYCLOHEXYLAMINE; DODECYL GALLATE; ERYTHROSINE; FERROCYANIDE; FOOD ADDITIVE; GALLIC ACID; GALLIC ACID PROPYL ESTER; NITRATE; NITRITE; TARTRAZINE; TIABENDAZOLE;

DIETARY INTAKE; FOOD SAFETY; HUMAN; NONHUMAN; REVIEW; RISK ASSESSMENT; SPECIES DIFFERENCE; TOXICITY TESTING; TOXICOKINETICS;

ANIMALS; FOOD ADDITIVES; HUMANS; NO-OBSERVED-ADVERSE-EFFECT LEVEL; TOXICITY TESTS;

ANIMALIA;

EID: 0033402905     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-6915(99)00107-6     Document Type: Review

References (197)

1. Acosta D., Sorensen E. M. B., Anuforo D. C., Mitchell D. B., Ramos K., Santone K. S. and Smith M. A. (1985) An in vitro approach to the study of target organ toxicity of drugs and chemicals. In Vitro Cell and Developmental Biology 21, 495-504.
2. Allan R. E. (1994) Phenols and phenolic compounds. In Patty's Industrial Hygiene and Toxicology, ed. G. D. Clayton and F. E. Clayton, 4th edn, pp. 1567-1630. Wiley, New York.
3. Allan R. J. and Roxon J. J. (1974) Metabolism by intestinal bacteria: the effect of bile salts on tartrazine azo reduction. Xenobiotica 4, 637-643.
4. Anderson K. J., Julshamn K. and Schjoensby H. (1979) Increased serum aluminum in patients with jaundice. New England Journal of Medicine 301, 728-729.
5. Anto R. J., George J., Babu K. V., Rajasekharan K. N. and Kuttan R. (1996) Antimutagenic and anticarcinogenic activity of natural and synthetic curcuminoids. Mutation Research 370, 127-131.
6. Astill B. D. and Mulligan L. T. (1977) Phenolic antioxidants and the inhibiton of hepatotoxicity from N-dimethylnitrosoamine formed in situ in the rat stomach. Food and Cosmetics Toxicology 15, 167-170.
7. Atterwill C. K., Johnston H. B. and Thomas S. M. (1996) Reversal of aluminium-induced metabolic changes in primary rat midbrain neural cultures by the NMDA antagonist MK-801. Toxicology in Vitro 10, 631-635.
8. Auletta A. E., Kuzava J. M. and Parmer A. S. (1977) Lack of mutagenic activity of a series of food dyes. Mutation Research 56, 203.
9. Azuine M. A., Kayal J. J. and Bhide S. V. (1992) Protective role of aqueous turmeric extract against mutagenicity of direct-acting carcinogens as well as benzo [alpha] pyrene-induced genotoxicity and carcinogenicity. Journal of Cancer Research and Clinical Oncology 118, 447-452.
10. Bartels M. J., McNett D. A., Timchalk C., Mendrala A. L., Christenson W. R., Sangha G. K., Brzak K. A. and Shabrang S. N. (1998) Comparative metabolism of ortho-phenylphenol in mouse, rat and man. Xenobiotica 28, 579-594.
11. Benford D. J. and Bridges J. W. (1980) Characterization of the activation of hepatic microsomal hydroxylation by betamethasone and alpha naphthoflavone. Biochemical Pharmacology 29, 2345-2349.
12. Bickel M. H., Burkard B., Meier S. E. and van-den-Broek B. M. (1974) Entero-bacterial formation of cyclohexylamine in rats ingesting cyclamate. Xenobiotica 4, 7-39.
13. Boegman R. J. and Bates L. A. (1984) Neurotoxicity of aluminium. Canadian Journal of Physiology and Pharmacology 62, 1010-1014.
14. Bonin A. M. and Baker R. S. U. (1980) Mutagenicity testing of some approed additives with Salmonella micrsome assay. Food Technology 32, 608.
15. Brown C. G. (1988) Application of thyroid cell culture to the study of thyrotoxicity. In In Vitro Methods in Toxicology, ed. C. Atterwill and C. E. Steele, pp. 165-188. Cambridge University Press, New York.
16. 14C-labelled FD & C Blue No. 1 (Brilliant Blue FCF) and its intestinal absorption and metabolic fate in rats. Food and Cosmetics Toxicology 18, 1-5.
17. Brown J. P., Roehm G. W. and Brown R. J. (1978) Mutagenicity testing of certified food colours and related azo, xanthane and triphenylmethane dyes with the Salmonella microsome system. Mutation Research 56, 249.
18. Burns T. S., Stargel W. W. and Hurwitz A. (1990) Bioavailability of phenylalanine and aspartate from aspartame (20 mg/kg) in capsules and solution. Metabolism 39, 1200-1203.
19. Calle L. M. and Sullivan P. D. (1982) Screening of antioxidants and other compounds for antimutagenic properties towards benzo[a]pyrene-induced mutagenicity in strain TA98 of Salmonella typhimurium. Mutation Research 101, 99-114.
20. Chambers P. L., Hunter C. G. and Stevenson D. E. (1966) Short-term study of Chocolate Brown HT in rats. Food and Cosmetics Toxicology 4, 151-155.
21. Chipman J. K. and Davies J. E. (1988) Reduction of 2-acetylaminofluorene-induced unscheduled DNA synthesis in human and rat hepatocytes by butylated hydroxytoluene. Mutation Research 207, 193-198.
22. Chipman J. K., Davies J. E. and Paterson P. (1987) Mechanisms of butylated hydroxytoluene-mediated modulation of 2-acetylaminofluorene mutagenicity in rat and human hepatocyte/Salmonella assays. Mutation Research 187, 105-112.
23. Chung K. T., Fulk G. E. and Egan M. (1978) Reduction of azo dyes by intestinal anaerobes. Applied and Environmental Microbiology 35, 558-562.
24. Conning D. M. and Phillips J. C. (1986) Comparative metabolism of BHA, BHT and other phenolic antioxidants and its toxicological relevance. Food and Chemical Toxicology 24, 1145-1148.
25. Creasy D. M., Ford G. R. and Gray T. J. (1990) The morphogenesis of cyclohexylamine-induced testicular atrophy in the rat: in vivo and in vitro studies. Experimental and Molecular Pathology 52, 155-169.
26. Creaven P. J., Parke D. V. and Williams R. T. (1965) A fluorimetric study of the hydroxylation of biphenyl in vitro by liver preparations of various species. Biochemical Journal 96, 879-885.
27. Davis T. R., Adler N. and Opsahl J. C. (1969) Excretion of cyclohexylamine in subjects ingesting sodium cyclamate. Toxicology and Applied Pharmacology 15, 106-116.
28. Davoli E., Cappellini L., Airoldi L. and Fanelli R. (1986) Serum methanol concentrations in rats and in men after a single dose of aspartame. Food and Chemical Toxicology 24, 187-189.
29. De BU and Crapper M. D. (1980) Senile dementia and Alzheimer's disease: A current view. Life Sciences 27, 1-14.
30. Depner M., Kahl G. F. and Kahl R. (1982) Influence of gallic acid esters on drug-metabolizing enzymes of rat liver. Food and Chemical Toxicology 20, 507-511.
31. Deshpande S. S. and Maru G. B. (1995) Effects of curcumin on the formation of benzo[alpha]pyrene derived DNA adducts in vitro. Cancer Letters 96, 71-80.
32. Doyle M. P., Pickering R. A., DeWeert T. M., Hoekstra J. W. and Pater D. (1981) Kinetics and mechanism of the oxidation of human deoxyhemoglobin by nitrites. Journal of Biological Chemistry 256, 12393-12398.
33. Drake J. J., Butterworth K. R., Guant I. F. and Hardy J. (1978) Long-term toxicity studies of Chocolate Brown HT in mice. Toxicology 10, 17-27.
34. Drasar B. S., Renwick A. G. and Williams R. T. (1972) The role of the gut flora in the metabolism of cyclamate. Biochemical Journal 129, 4-90.
35. Eaton E. A., Walle U. K., Lewis A. J., Hudson T., Wilson A. A. and Walle T. (1996) Flavonoids, potent inhibitors of the human P-form phenolsulfotransferase: Potential role in drug metabolism and chemoprevention. Drug Metabolism and Disposition 24, 232-237.
36. Ekins S. (1996) Past, present, and future applications of precision-cut liver slices for in vitro xenobiotic metabolism. Drug Metabolism Reviews 28, 591-623.
37. Ernst V. W. (1965) Transformation and elimination of 2-hydroxydiphenyl in the rat. Drug Research 37, 636.
38. Fisher R., Brendel K. and Hanzlik R. P. (1993) Correlation of metabolism, covalent binding and toxicity for a series of bromobenzene derivatives using rat liver slices in vitro. Chemico-Biological Interactions 88, 191-198.
39. Forero D. W. and Kock M. M. (1942) Cited from WHO Food Additive Series No. 5. 43.
40. Fountain S. B., Hennes S. K. and Teyler T. J. (1988) Aspartame exposure and in vitro hippocampal slice excitability and plasticity. Fundamental and Applied Toxicology 11, 221-228.
41. Fritsch P., De Saint Blanquat G. and Derache R. (1985) Excretion of nitrates and nitrites in saliva and bile in the dog. Food and Chemical Toxicology 23, 655-659.
42. Gardner D. F., Utiger R. D., Schwartz S. L., Witorsch P., Meyers B., Braverman L. E. and Witorsch R. J. (1987) Effects of oral erythrosine (2′,4′,5′,7′-tetraiodofluorescein) on thyroid function in normal men. Toxicology and Applied Pharmacology 91, 299-304.
43. Garside D. A. (1988) Use of in vitro techniques to investigate the action of testicular toxicants. In In Vitro Methods in Toxicology, ed. C. Atterwill and C. E. Steele, pp. 411-423. Cambridge University Press, New York.
44. Gatseva P., Marinova S. and Vurtigova L. (1992) [Changes in the thyroid and other internal organs of experimental animals exposed to a drinking regimen with a high nitrate content]. Problemi na Khigienta 17, 43-47.
45. Gaunt I. F., Hardy J., Grasso P., Gangolli S. D. and Butterworth K. R. (1976) Long-term toxicity of cyclohexylamine hydrochloride in rat. Food and Cosmetics Toxicology 14, 255-267.
46. Ghosal A. and Iba M. M. (1992) Enhancement by butylated hydroxytoluene of the in vitro activation of 3,3′-dichlorobenzidine. Mutation Research 278, 31-41.
47. Gidden H., Holland F. F. and Klein E. (1980) Trace metal protein binding in normal and dialyzed uremic patients. Journal of Nephrology 26, 133-138.
48. Gobin S. J., Legg R. F., Paine A. J. and Phillips J. A. (1989) The effect of 2-acetyl-4-tetrahydroxybutylimidazole on lymphocyte subsets in peripheral blood in the rat. International Journal of Immunopharmacology 11, 937-946.
49. Gobin S. J. and Paine A. J. (1989) Effect of oral and parenteral administration of B6 vitamins on the lymphopenia produced by feeding ammonia caramel or 2-acetyl-4-tetrahydroxybutyllimidazole to rats. Food and Chemical Toxicology 27, 627-630.
50. Gorsky J. E., Dietz H., Spencer H. and Osis D. (1979) Metabolic balance of aluminium studied in six men. Clinical Chemistry 25, 1739-1743.
51. Grant D. and Gaunt I. F. (1987) Teratogenicity and embryotoxicity study of Brown HT in the rat. Food and Chemical Toxicology 25, 1009-1011.
52. Greenberg L. A. and Lester D. (1947) The metabolic fate of acetanilid and other aniline derivatives. III. The role of p-aminophenol in the production of methaemoglobin after acetanillid. Journal of Pharmacology and Experimental Therapeutics 90, 150-155.
53. Greger J. M. and Baier M. J. (1983) Excretion and retention of low or moderate levels of aluminium by human subjects. Food and Chemical Toxicology 21, 473-477.
54. Hall D. E., Lee F. S. and Fairweather F. A. (1966) Acute (mouse and rat) and short-term (rat) toxicity studies on chocolate brown HT. Food and Cosmetics Toxicology 4, 143-149.
55. Haram E. M. and Weberg A. (1987) Urinary excretion of aluminium after ingestion of sucralgate and an aluminium-containing antacid in man. Scandanavian Journal of Gastroenterology 22, 615-615.
56. Hardy J., Gaunt I. F., Hooson J., Hendy R. J. and Butterworth K. R. (1976) Long-term toxicity of cyclohexylamine hydrochloride in mice. Food and Cosmetics Toxicology 14, 269-276.
57. Harman A. W. and Fischer L. J. (1983) Hamster hepatocytes in culture as a model for acetaminophen toxicity. Toxiology and Applied Pharmacology 71, 330-341.
58. Haveland S. R., Combes R. D. and Bridges B. A. (1980) Studies on the genotoxicity of some fluorescein dyes. Mutation Research 88, 1-15.
59. Hawkins R. (1979) Lung damage and butylated hydroxytoluene. Food and Cosmetics Toxicology 15, 278-298.
60. Heizer W. D. and Laster L. (1969) Hydrolases in the mucosa of rat small intestine for phenylalanine-containing dipeptides. Biochimica et Biophysica Acta 185, 409-423.
61. Hess S. M. and Fitzhugh O. G. (1953) Metabolism of coal-tars dyes. I. Triphenylamine dyes. (Absract No. 1090). Federation Proceedings 12, 330-331.
62. Hess S. M. and Fitzhugh O. G. (1955) Absorption and excretion of certain triphenylmethane colors in rats and dogs. Journal of Pharmacology and Experimental Therapeutics 114, 38-42.
63. Heubner W. (1913) Studien uber Methamoglobinbildung. Naunyn-Schmieldbergs Archives of Experimentalle Pathologie und Pharmakologie 72, 239-243.
64. Hiraga K. and Fujii T. (1984) Induction of tumours of the urinary bladder in F344 rats by dietary administration of o-phenylphenol. Food and Chemical Toxicology 22, 865-870.
65. Hirose M., Masuda A., Fukushima S. and Ito N. (1988) Effects of subsequent antioxidant treatment on 7,12-dimethylbenz[a]anthracene-initiated carcinogenesis of the mammary gland, ear duct and forestomach in Sprague-Dawley rats. Carcinogenesis 9, 101-104.
66. Hohr D., Abel J. and Willheim M. (1989) Renal clearance of aluminium: studies in the isolated pefused rat kidney. Toxicology Letters 45, 165-174.
67. Holder G. M., Plummer J. L. and Ryan A. J. (1978) The metabolism and excretion of curcumin (1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) in the rat. Xenobiotica 8, 761-768.
68. Hollosi M., Holly S., Majer Z., Laczko I. and Fasman G. D. (1995) Complexes of aluminium with peptide ligands: a Fourier transform IR spectroscopic study. Biopolymers 36, 3-9.
69. Horing H., Ellinger C., Nagel M., Paldy A. and Desi I. (1986) [The action of phenylmercuriacetate and nitrate in combined application in rats: the thyroid gland, liver enzymes and morphologic findings in the brain and kidney]. Nahrung 30, 713-721.
70. Houben G. F., Abma P. H., Van-Den B. H., Van D. W., Van L. H., Penninks A. H., Seinen W., Spanhaak S., Vos J. G. and Ockhuizen T. (1992) Effects of the colour additive Caramel Colour III on the immune system: A study with human volunteers. Food and Chemical Toxicology 30, 749-757.
71. Houben G. F., Van D. W., Van L. H., Penninks A. H., Seinen W., Spanhaak S. and Ockhuizen T. (1992) Effects of Caramel Colour III on the number of blood lymphocytes: A human study on Caramel Colour III immunotoxicity and a comparison of the results with data from rat studies. Food and Chemical Toxicology 30, 427-430.
72. Hutchinson A. P., Carrick B., Miller K. and Nicklin S. (1992) Adverse reactions to synthetic food colours: interactions between tartrazine and muscarinic acetylcholine receptors in isolated guinea-pig ileum. Toxicology Letters 60, 165-173.
73. 1 mice. Japanese Journal of Cancer Research 79, 49-58.
74. Iscaro A., Mackay I. R. and O'Brien C. (1988) Lyphopenic effects of mice of a component of ammonia caramel, 2-acetyl-5-tetrahydroxybutylimidazole. Immunology and Cell Biology 66, 395-402.
75. Ishidate M., Sofuni T., Hayashi M., Nohmi T., Sawada M. and Matsuko A. (1984) Primary mutagenicity screening of food additives currently used in Japan. Food and Chemical Toxicology 22, 623-626.
76. Jahreis G., Hesse V., Schone F., Hennig A. and Gruhn K. (1986) Effect of chronic dietary nitrate and different iodine supply on porcine thyroid function, somatomedin-C-level and growth. Experimental and Clinical Endocrinology 88, 242-248.
77. Jenkins F. P. (1966a) Metabolism of Red 2G by rat liver homogenate. Unpublished report from Unilever Research Laboratories, submitted to WHO by Unilever Ltd.
78. Jenkins F. P. (1966b) Effects of diets containing aniline and metabolites of aniline on spleen weights. Unpublished report from Unilever Research Laboratories, submitted to WHO by Unilever Ltd.
79. Jenkins F. P., Robinson J. A., Gellately J. B. M. and Salmond G. W. A. (1972) The no-effect of aniline in human subjects and a comparison of aniline toxicity in man and the rat. Food and Cosmetics Toxicology 10, 671-679.
80. Jennings A. S., Schwartz S. L., Balter N. J., Gardner D. and Witorsch R. J. (1990) Effects of oral erythrosine (2′,4′,5′,7′-tetraiodofluorescein) on the pituitary-thyroid axis in rats. Toxicology and Applied Pharmacology 103, 549-556.
81. Jones R., Ryan A. J. and Wright S. E. (1964) The metabolism and excretion of tartrazine in the rat, rabbit and man. Food and Cosmetics Toxicology 2, 447-452.
82. Julka D. and Gill K. D. (1996) Altered calcium homeostasis: a possible mechanisms of aluminium-induced neurotoxicity. Biochimica et Biophysica Acta 1315, 47-54.
83. Katsuyama H., Saijoh K., Inoue Y. and Sumino K. (1989) The interaction of aluminium with soluble protein kinase C from mouse brain. Archives of Toxicology 63, 474-478.
84. Kleeman C. R. and Epstein F. H. (1956) Fate and distribution of Fe59 labelled ferrocyanide in humans and dogs. Proceedings of the Society for Experimental Biology and Medicine 93, 228-233.
85. Klein G. L., Alfrey A. C., Miller N. L., Sherrard T. K., Hazlet M., Ament M. E. and Coburn J. W. (1982) Aluminium loading during total parenteral nutrition. American Journal of Clinical Nutrition 35, 1425-1429.
86. Konetzka W. A. (1974) Mutagenesis by nitrate reduction in Escherichia coli. Abstract. Annual Meeting American Society of Microbiology, Washington. Abstract No. G106.
87. Kovalchik M. T., Kaehny W. D. and Hegg A. P. (1978) Aluminium kinetics during dialysis. Journal of Laboratory and Clinical Medicine 92, 712-720.
88. Kwok E. S. and Eastmond D. A. (1997) Effects of pH on nonenzymatic oxidation of phenylhydroquinone: potential role in urinary bladder carcinogenesis induced by o-phenylphenol in Fischer 344 rats. Chemical Research in Toxicology 10, 742-749.
89. Lakdawalla A. A. and Netrawali M. S. (1988a) Mutagenicity, co-mutagenicity, and antimutagenicity of erythrosine (FD and C red 3), a food dye, in the Ames/ Salmonella assay. Mutation Research 204, 131-139.
90. Lakdawalla A. A. and Netrawali M. S. (1988b) Erythrosine, a permitted food dye, is mutagenic in the Bacillus subtilis multigene sporulation assay. Mutation Research 206, 171-176.
91. Lake B. G., Ball S. E., Renwick A. B., Tredger J. M., Kao J. Beamand J.A. and Price R. J. (1997) Induction of CYP3A isoforms in cultured precision-cut human liver slices. Xenobiotica 27, 1165-1173.
92. Leahy J. S., Taylor T. and Rudd C. J. (1967) Cyclohexylamine excretors among human volunteers given cyclamate. Food and Cosmetics Toxicology 5, 4-6.
93. Lehman A. J. and Fitzhugh O. G. (1954) 100-Fold margin of safety. Association of Food Drug Officers . U.S.Q. Bulletin 18, 33-35.
94. Lijinsky W., Kovatch R. and Riggs C. W. (1983) Altered incidences of hepatic and hemopoietic neoplasms in F344 rats fed sodium nitrite. Carcinogenesis 4, 1189-1191.
95. Lipschitz W. (1920) Mechanisms der Giftwirkung aromatischer Nitroverbindungen zugleich ein Betrag zum Atmungsproblem tiericher und pflanzlicher Zellen. Hoppe Seyler's Zeitschrift für Physiologie Chemie 109, 189-193.
96. Litchfield M. H. and Swan A. A. B. (1971) Cyclohexylamine production and physiological measurements in subjects ingesting sodium cyclamate. Toxicology and Applied Pharmacology 18, 535-541.
97. Luca D., Raileanu L., Luca Y. and Duda R. (1985) Chromosomal aberrations and micronuclei induction in rat and mouse bone marrow cells by sodium nitrate. Mutation Research 155, 121-125.
98. Maekawa A., Ogiu T., Onodera H., Furuta A., matsuoka C., Ohno Y. and Odashima S. (1982) Carciogenicity studies of sodium nitrite and sodium nitrate in F-344 rats. Food and Chemical Toxicology 20, 25-33.
99. Mallett A. K., Bearne C. A. and Rowland I. R. (1986) The use of continuous flow systems for studying the metabolic activity of the hindgut microflora in vitro. Food and Chemical Toxicology 24, 743-747.
100. Mason P. L. and Thompson G. R. (1977) Testicular effects of cyclohexylamine hydrochloride in the rat. Toxicology 8, 143-156.
101. Matula T. I. and Downie R. H. (1984) Genetic toxicity of erythrosine in yeast. Mutation Research 138, 153-156.
102. Mehendale H. M. (1989) Application of isolated organ techniques in toxicology. In Prinicipals and Methods of Toxicology, ed. A. W. Hayes, pp. 699-740. Raven Press, New York.
103. Meyer T. and Scheline R. R. (1979) The metabolism of biphenyl. II. Phenolic metabolites in the rat. Acta Pharmacology and Toxicology 39, 433-441.
104. Mitoma C., Lawson J. R., Miller I. H. and Mathura G. R. (1956) The fate of diphenyl in the rat. Archives of Biochemistry and Biophysics 60, 14-20.
105. Morimoto K., Sato M., Fukuoka M., Hasegawa R., Takahashi T., Tsuchiya T., Tanaka A., Takahashi A. and Hayashi Y. (1989) Correlation between the DNA damage in urinary bladder epithelium and the urinary 2-phenyl-1,4-benzoquinone levels from F344 rats fed sodium o-phenylphenate in the diet. Carcinogenesis 10, 1823-1827.
106. Muller J. P. and Bruinink A. (1994) Neurotoxic effects of aluminium on embryonic chick brain cultures. Acta Neuropathology Berlin 88, 359-366.
107. Nagabhushan M., Amonkar A. J. and Bhide S. V. (1987) In vitro antimutagenicity of curcumin against environmental mutagens. Food and Chemical Toxicology 25, 545-547.
108. Nakagawa Y. and Tayama S. (1996) Induction of 8-hydroxy-2′-deoxyguanosine in CHO-K1 cells exposed to phenyl-hydroquinone, a metabolite of ortho-phenylphenol. Cancer Letters 101, 227-232.
109. Nakagawa Y., Nakajima K., Tayama S. and Moldeus P. (1995) Metabolism and cytotoxicity of propyl gallate in isolated rat hepatocytes: effects of a thiol reductant and an esterase inhibitor. Molecular Pharmacology 47, 1021-1027.
110. Nakagawa Y., Tayama S., Moore G. A. and Moldeus P. (1992) Relationship between metabolism and cytotoxicity of ortho-phenylphenol in isolated rat hepatocytes. Biochemical Pharmacology 43, 1431-1437.
111. Nakagawa Y., Tayama S., Moore G. A. and Moldeus P. (1995) Cytotoxic effects of biphenyl and hydroxybiphenyls on isolated rat hepatocytes. Biochemical Pharmacology 45, 1959-1965.
112. Nakao T., Ushiyama K., Kabashima J., Nagai F., Nakagawa A., Ohno T., Ichikawa H., Kobayashi H. and Hiraga K. (1983) The metabolic profile of sodium o-phenylphenate after subchronic oral administration to rats. Food and Chemical Toxicology 21, 325-329.
113. Oetari S., Sudibyo M., Commandeur J. M., Samhoedi R. and Vermeulen N. E. (1996) Effects of curcumin on cytochrome P450 and glutathione S-transferase activities in rat liver. Biochemical Pharmacology 51, 39-45.
114. Olsen P., Meyer O., Bille N. and Wurtzen G. (1986) Carcinogenicity study on butylated hydroxytoluene (BHT) in Wistar rats exposed in utero. Food and Chemical Toxicology 24, 1-12.
115. Ondreicka R., Ginter E. and Kortus J. (1966) Chronic toxicity of aluminium in rats and mice and its effects on phosphorus metabolism. British Journal of Industrial Medicine 23, 305-312.
116. Pai S. M. and Melethil S. (1989) Kinetics of aluminium in rats I: Dose-dependent elimination from blood after intravenous administration. Journal of Pharmaceutical Science 78, 200-202.
117. Parkinson A. and Safe S. (1982) Cytochrome P450-mediated metabolism of biphenyl and the halobiphenyls. Biochemical Pharmacology 31, 1849-1856.
118. Paul T., Meyers B., Witorsch R. J., Pino S., Chipkin S., Ingbar S. H. and Braverman L. E. (1988) The effect of small increases in dietary iodine on thyroid function in euthyroid subjects. Metabolism Clinical and Experimental 32, 121-124.
119. Phillips J. C., Mendis D., Eason C. T. and Gangolli S. D. (1980) The metabolic disposition of (14)C-labelled Green S and Brilliant Blue FCF in the rat, mouse and guinea pig. Food and Cosmetics Toxicology 18, 7-13.
120. Phillips J. C., Mendis D. and Gaunt I. F. (1987) Metabolic disposition of 14C-labelled Brown HT in the rat, mouse and guinea-pig. Food and Chemical Toxicology 25, 1013-1019.
121. Pogglitsch H., Wawschinek O. and Holzer H. (1980) Relationships between plasma aluminium, peroral aluminiumhydroxyde intake and symptoms of encephalopathy in patients on. Nieren und Hochdruckkrankheiten 109, 284-289.
122. Pradhan A. and Majumdar M. K. (1986) Metabolism of some drugs by intestinal lactobacilli and their toxicological considerations. Acta Pharmacology and Toxicology 58, 11-15.
123. Price R. J., Renwick A. B., Wield P. T., Beamand J. A. and Lake B. G. (1995) Toxicity of 3-methylindole, 1-nitro-naphthalene and paraquat in precision-cut rat lung slices. Archives of Toxicology 69, 405-409.
124. Quast J. F., McGuirk R. J. and Kociba R. J. (1997) Results of a two-year dietary toxicity/oncogenicity study of ortho-phenylphenol (OPP) in B6C3F1 mice. Toxicologist 36, 341.
125. Rahimtula A., Zachariah P. and O'Brien P. (1979) Differential effects of antioxidants, steroids and other compounds on benzo(a)pyrene 3-hydroxylase activity in various tissues of rats. British Journal of Cancer 40, 105-112.
126. Raj A. S. and Katz M. (1984) Corn oil and its minor constituents as inhibitors of DMBA-induced chromosomal breaks in vivo. Mutation Research 136, 247-253.
127. Rasheva V., Yantchev I., Boshilova N. and Panova M. (1990) Cytogenetic and pathohistological changes in mice treated with sodium nitrate: dynamics of the changes for 5 to 15 days. Comptes Rendus de l'Academie Bulgare des Sciences 43, 93-94.
128. Ravindranath V. and Chandrasekhara N. (1982) Metabolism of curcumin - studies with [(3)H]curcumin. Toxicology 22, 337-344.
129. Reddy B. S., Sharma C. and Mathews L. (1983) Effect of butylated hydroxytoluene and butylated hydroxyanisole on the mutagenicity of 3,2′-dimethyl-4-aminobiphenyl. Nutrition and Cancer 5, 153-158.
130. Reilly M. A., Debler E. A., Fleischer A. and Lajtha A. (1989) Chronic aspartame ingestion does not alter cerebral levels of aminergic neurotransmitters and related amino acids in the rat brain. Research Communications in Psychology and Psychiatric Behaviour 14, 287-303.
131. Reitz R. H., Fox T. R., Quast J. F., Hermann E. A. and Watanabe P. G. (1983) Molecular mechanisms involved in the toxicity of orthophenylphenol and its sodium salt. Chemico-Biological Interactions 43, 99-119.
132. Reitz R. H., Fox T. R., Quast J. F., Hermann E. A. and Watanabe P. G. (1984) Biochemical factors involved in the effects of orthophenylphenol (OPP) and sodium orthophenylphenate (SOPP) on the urinary tract of male F344 rats. Toxicology and Applied Pharmacology 73, 345-349.
133. Renwick A. G. (1991) Safety factors and establishment of acceptable daily intakes. Food Additives and Contaminants 8, 135-149.
134. Renwick A. G. (1993) Data-derived safety factors for the evaluation of food additives and environmental contaminants. Food Additives and Contaminants 10, 275-305.
135. Renwick A. G. and Williams R. T. (1972) The fate of cyclamate in man and other species. Biochemical Journal 129, 4-79.
136. Richer N., Marion M. and Denizeau F. (1989) Inhibition of binding of 2-acetylaminofluorene to DNA by butylated hydroxytoluene in vitro. Cancer Letters 47, 211-216.
137. Roberts A. and Renwick A. G. (1985) The metabolism of 14C-cyclohexylamine in mice and two strains of rat. Xenobiotica 15, 477-483.
138. Roberts A. and Renwick A. G. (1989) The pharmacokinetics and tissue concentrations of cyclohexylamine in rats and mice. Toxicology and Applied Pharmacology 98, 230-242.
139. Rofe P. (1957) Azo dyes and Heinz bodies. British Journal of Industrial Medicine 14, 275-280.
140. Rogers C. G., Boyes B. G., Matula T. I., Heroux M. C. and Clayson D. B. (1988) A case report: A multiple end-point approach to evaluation of cytotoxicity and genotoxicity of erythrosine (FD and C Red No. 3) in a V79 hepatocyte-mediated mutation assay. Mutation Research 205, 415-423.
141. Roll M., Banin E. and Meiri H. (1989) Differentiated neuroblastoma cells are more susceptible to aluminium toxicity than developing cells. Archives of Toxicology 63, 231-237.
142. Rosin M. P. and Stich H. F. (1980) Enhancing and inhibiting effects of propyl gallate on carcinogen-induced mutagenesis. Journal of Environmental Pathology and Toxicology 4, 159-167.
143. Roxon J. J., Ryan A. J. and Wright S. E. (1966) Reduction of tartrazine by a Proteus species isolated from rats. Food and Cosmetics Toxicology 4, 419-426.
144. Roy D. (1990) Cytochrome P-450 catalyzed redox cycling of orthophenylphenol. Biochemistry International 22, 849-857.
145. Ruben Z., Fuller G. C. and Knodle S. G. (1984) Disobutamide-induced cytoplasmic vacuoles in cultured dog coronary artery muscle cells. Archives of Toxicology 55, 206-212.
146. Ruiz M. and Ingbar S. H. (1982) Effect of erythrosine (2′,4′,5′,7′-tetraiodofluorescein) on the metabolism of thyroxine in rat liver. Endocrinology 110, 1613-1617.
147. Sankaranarayanan N. and Murthy M. S. S. (1979) Testing of some permitted food colours for the induction of gene conversion by diploid yeast. Mutation Research 67, 309-314.
148. Seffner W. (1985) Zum Einfluss von subchronishcher Nitrataapplikation mit trinkwasser auf die Schilddruse der ratte. Gesundheit und Umwelt 4, 16-30.
149. Shelef L. A. and Chin B. B. (1980) Effect of phenolic antioxidants on the mutagenicity of aflatoxin B1. Applied and Environmental Microbiology 40, 1039-1043.
150. Shirai T., Ikawa E., Hirose M., Thamavit W. and Ito N. (1985) Modification by five antioxidants of 1,2-dimethylhydrazine-initiated colon carcinogenesis in F344 rats. Carcinogenesis 6, 637-639.
151. Sinkledam E. J. (1981) Quantitative relationship between dietary pyridoxine content and lymphocyte counts in rats fed ammonia caramel. Unpublished report No. V81. 390/211704 from Centraal Instituut voor Voedingsonderzoek (CIVO/TNO), Zeist, The Netherlands. Submitted to WHO.
152. Sinkeldam E. J. (1982) Quanitive relationship between dietary pyridoxine content and lymphocyte counts in mature rats fed ammonia caramel. Unpublished report No. V81. 102/2201102 from Centraal Instituut voor Voedingsonderzoek (CIVO/TNO), Zeist, The Netherlands. Submitted to WHO.
153. Sinkeldam E. J., de Groot A. P., van den Berg H. and Chappel C. I. (1988) The effect of pyridoxine on the number of lymphocytes in the blood of rats fed Caramel Colour (III). Food and Chemical Toxicology 26, 195-203.
154. Smith M. A., Acosta D. and Bruckner J. V. (1987) Cephaloridine toxicity in primary cultures of rat renal epithelial cells. In Vitro Toxicology 1, 29.
155. Soni K. B., Lahiri M., Chackradeo P., Bhide S. V. and Kuttan R. (1997) Protective effect of food additives on aflatoxin-induced mutagenicity and hepatocarcinogenicity. Cancer Letters 115, 129-133.
156. Sonnewald U., Muller T., Unsgard G. and Petersen S. B. (1995) Effects of aspartame on 45Ca influx and LDH leakage from nerve cells in culture. Neuroreport 6, 318-320.
157. Soudamini K. K., Unnikrishnan M. C., Sukumaran K. and Kuttan R. (1995) Mutagenicity and anti-mutagenicity of selected spices. Indian Journal of Physiology and Pharmacology 39, 347-353.
158. Spector R. and Huntoon S. (1982) Effects of caramel color (ammonia process) on mammalian vitamin B6 metabolism. Toxicology and Applied Pharmacology 62, 172-178.
159. Spencer P. S., Cain S. M., Bornstein M. B., Peterson E. R. and vab de Water T. (1986) Chemical neurotoxicity: detection and analysis in organotypic cultures of sensory and motor systems. Food and Chemical Toxicology 24, 540.
160. Stammati A. P., Silano V. and Zucco F. (1981) Toxicology investigations with cell culture systems. Toxicology 20, 91-153.
161. Susan M. and Rao M. N. (1992) Induction of glutathione S-transferase activity by curcumin in mice. Arzneimittelforschung 42, 962-964.
162. Suzuki H., Suzuki N., Sasaki M. and Hiraga K. (1985) Orthophenylphenol mutagenicity in a human cell strain. Mutation Research 156, 123-127.
163. Takahashi O. and Hiraga K. (1981) Haemorrhagic toxicosis in rats given butylated hydroxytoluene. Acta Pharmacology and Toxicology 49, 14-20.
164. Tarjan V. and Kurti M. (1982) Mutagenicity testing of several food colorants certified for use in Hungary. Mutation Research 97, 228.
165. Tayama S. and Nakagawa Y. (1994) Effect of scavengers of active oxygen species on cell damage caused in CHO-K1 cells by phenylhydroquinone, an o-phenylphenol metabolite. Mutation Research 324, 121-131.
166. Tocco D. J., Rosenblum C., Martin C. M. and Robinson H. J. (1966) Absorption, metabolism, and excretion of thiabendazole in man and laboratory animals. Toxicology and Applied Pharmacology 9, 31-39.
167. Trapp G. A. (1983) Plasma aluminium is bound to transferrin. Life Sciences 33, 311-316.
168. Ushiyama K., Nagai F., Nakagawa A. and Kano I. (1992) DNA adduct formation by o-phenylphenol metabolite in vivo and in vitro. Carcinogenesis 13, 1469-1473.
169. van M. J., van D. A., Mulder K., de BM, Menheere P. C., van-der H. D., Mertens P. L. and Kleinjans J. C. (1994) Consumption of drinking water with high nitrate levels causes hypertrophy of the thyroid. Toxicology Letters 72, 365-374.
170. Van W. R., van-der V. G., Marani E., Van-Keep J. P. and De W. F. (1989) Morphological effects of aluminium on rat hippocampal neurons in culture. Acta Morphologica Neerlando Scandinavica 27, 211-213.
171. van Maanen J. M., van Dijk A., Mulder K., De-Baets M. H., Menheere P. C., van der Heide D., Mertens P. L. and Kleinjans J. C. (1994) Consumption of drinking water with high nitrate levels causes hypertrophy of the thyroid. Toxicology Letters 72, 365-374.
172. Vecchierini B. M., Thebaud H. E., Brochard D. and Coville P. (1980) [Two forerunners of the encephalopathy of hemodialysed patients: osteomalacic osteodystrophy and electroencephalographic alterations. Influence of the aluminium concentration in the dialysis fluid (author's transl)]. Nephrologie 1, 29-32.
173. Vickers A. E., Connors S., Zollinger M., Biggi W. A., Larrauri A., Vogelaar J. P. and Brendel K. (1993) The biotransformation of the ergot derivative CQA 206-291 in human, dog, and rat liver slice cultures and prediction of in vivo plasma clearance. Drug Metabolism and Disposition 21, 454-459.
174. von Issekutz B. (1939) Studien uber Methamoglobinbildung. Archib fur Experimentelle Pathologie und Pharmakologie 193, 551-552.
175. Wahle B. S., Christenson W. R., Laske S. G., Elcock L. E., Moore K. D., Sangha G. K. and Thyssen J. H. (1997) Technical grade oryho-phenylphenol: a combined chronic toxicity/oncogenicity testing study in the rat. Toxicologist 36, 341.
176. Walker R. (1971) Cited from Who Food Additives Series 16. JECFA 25/169 1981.
177. Werberg R. and Berstad A. (1986) Gastrointestinal absorption of aluminium from single doses of aluminium containing antacids in man. Journal of Clinical Investigation 16, 428-432.
178. WHO (1964a) Toxicological evaluation of certain food additives and contaminants. Food Additive Series No. 66. 25, World Health Organization, Geneva.
179. WHO (1964b) Toxicological evaluation of certain food additives and contaminants. Food Additive Series No. 24. 65, World Health Organization, Geneva.
180. WHO (1969) Toxicological evaluation of certain food additives and contaminants. Food Additive Series No. 70. 37, World Health Organization, Geneva.
181. WHO (1974) Toxicological evaluation of certain food additives and contaminants. Food Additive Series No. 6, World Health Organization, Geneva.
182. WHO (1981) Toxicological evaluation of certain food additives and contaminants. Food Additive Series No. 16, World Health Organization, Geneva.
183. WHO (1982) Toxicological evaluation of certain food additives and contaminants. Food Additive Series No. 17, World Health Organization, Geneva.
184. WHO (1984) Toxicological evaluation of certain food additives and contaminants. Food Additive Series No. 19, World Health Organization, Geneva.
185. WHO (1987) Toxicological evaluation of certain food additives and contaminants. Food Additive Series No. 29, World Health Organization, Geneva.
186. WHO (1988) Toxicological evaluation of certain food additives and contaminants. Food Additive Series No. 24, World Health Organization, Geneva.
187. WHO (1991) Toxicological evaluation of certain food additives and contaminants. Food Additive Series No. 28, World Health Organization, Geneva.
188. WHO (1993a) Toxicological evaluation of certain food additives and contaminants. Food Additive Series No. 32, World Health Organization, Geneva.
189. WHO (1993b) Toxicological evaluation of certain veterinary drug residues in food. Food Additive Series No. 31, World Health Organization, Geneva.
190. WHO (1994) Assessing Human Health Risks of Chemicals: Derivation of Guidance Values for Health Exposure Limits. Environmental Health Criteria, Vol. 170. World Health Organization, Geneva.
191. WHO (1995) Toxicological evaluation of certain food additives and contaminants. Food Additive Series No. 35, World Health Organization, Geneva.
192. WHO (1996) Toxicological evaluation of certain food additives and contaminants. Food Additive Series No. 36, World Health Organization, Geneva.
193. Wiebkin P., Fry J., Jones C. A., Lowing R. K. and Bridges J. W. (1978) Biphenyl metabolism in isolated rat hepatocytes: Effect of induction and nature of the conjugates. Biochemical Pharmacology 27, 1899-1907.
194. Willheim M., Sprenger K. B. G., Vossas U. and Ohnesorge F. K. (1986) Aluminium load in chronic plasma osteodystrophy with liver disease. Clinical Toxicology 25, 209-220.
195. Wills J. H., Serrone D. M. and Coulston F. (1981) A 7-month study of ingestion of sodium cyclamate by human volunteers. Regulatory Toxicology and Pharmacology 5, 172-176.
196. Wing A. J., Brunner F. P. and Brynger H. et al. (1980) Dialysis dementia in Europe. Report from the Registration Committee of the European Dialysis and Transplant Association. Lancet ii, 190-192.
197. Yang C. S. and Strickhart F. S. (1974) Inhibition of hepatic mixed function oxidase activity by propyl gallate. Biochemical Pharmacology 23, 3129-3138.